Citalopram neuropharmacological challenge in alcohol-dependent patients and controls: Pharmacogenetics endocrine and psychobehavioral results

Pharmacopsychiatry

Volumn 41, Issue 2, 2008, Pages 72-78

  Wong, W M ^a,c   Hasemann, S ^a   Schwarz, M ^a   Zill, P ^a   Koller, G ^a   Soyka, M ^a,d   Preuss, U W ^a,b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c Psychiatric Hospital Haar   (Germany)

^d Private Hospital   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; CORTICOTROPIN; PLACEBO; SEROTONIN 2C RECEPTOR;

ADULT; ALCOHOL INTOXICATION; ALCOHOLISM; ANXIETY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA POLYMORPHISM; DOUBLE BLIND PROCEDURE; HORMONE BLOOD LEVEL; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; PHARMACOGENETICS; PRIORITY JOURNAL; RATING SCALE; SEROTONIN SYNDROME SCALE; TREATMENT RESPONSE; VISUAL ANALOG SCALE; WITHDRAWAL SYNDROME;

ADRENOCORTICOTROPIC HORMONE; ADULT; ALCOHOLISM; ALLELES; ANTIDEPRESSIVE AGENTS; ANXIETY; BEHAVIOR; CITALOPRAM; DOUBLE-BLIND METHOD; GENE FREQUENCY; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LIMBIC SYSTEM; MALE; PITUITARY-ADRENAL SYSTEM; POLYMORPHISM, GENETIC; PSYCHIATRIC STATUS RATING SCALES; RECEPTOR, SEROTONIN, 5-HT2C; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN SYNDROME;

EID: 41149119960     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1004595     Document Type: Article

References (32)

1. Adinoff B, Junghanns K et al. Suppression of the HPA axis stress-response: implications for relapse. Alcohl Clin Exp Res 2005; 29: 1351-1355
2. Adinoff B, Ruether K et al. Increased salivary cortisol concentrations during chronic alcohol intoxication in a naturalistic clinical sample of men. Alcohol Clin Exp Res 2003; 27: 1420-1427
3. Angelone SM, Bellini L et al. Effects of fluvoxamine and citalopram in maintaining abstinence in a sample of Italian detoxified alcoholics. Alcohol 1988; 33: 151-156
4. Bucholz KK, Cadoret R et al. A new, semi-structured psychiatric interview for use in genetic linkage studies: A report on the reliability of the SSAGA. J Stud Alcohol 1995; 55: 149-158
5. Cook EH, Courchensne R et al. Evidence of linkage between the serotonin transporter and autistic disorder. Mol Psychiatry 1997; 2: 247-250
6. Done CJ, Sharp T. Biochemical evidence for the regulation of central noradrenergic activity by 5-HT1A and 5-HT2 receptors: microdialysis studies in the awake and anaesthetized rat. Neuropharmacology 1994; 33: 411-421
7. Doudet D, Hommer D et al. Cerebral glucose metabolism, CSF 5-HIAA levels, and aggressive behavior in rhesus monkeys. Am J Psychiatry 1995; 152: 1782-1787
8. Ehrenreich H, Schuck J et al. Endocrine and hemodynamic effects of stress versus systemic CRF in alcoholics during early and medium term abstinence. Alcohol Clin Exp Res 1997; 21: 1285-1293
9. Enrico AL, Parson OA et al. Attenuated cortisol response to biobehavioral stressors in sober alcoholics. J Stud Alcohol 1993; 54: 393-398
10. Farren CK, O'Malley SS et al. Variable dose naltrexone-induced hypothalamic-pituitary-adrenal stimulation in abstinent alcoholics: a preliminary study. Alcohl Clin Exp Res 1999; 23: 502-508
11. Geracioti TD, Goldsmith RJ et al. Cerebrospinal fluid neuroendocrinology of alcohol misusers. Addict Biol 1997; 2: 401-409
12. Geracioti TD, Loosen PT et al. Concentrations of corticotropin-releasing hormone, norepinephrine, MHPG, 5-hydroxyindoleacetic acid, and tryptophan in the cerebrospinal fluid of alcoholic patients: Serial sampling studies. Neuroendocrinology 1994; 60: 635-642
13. Heinz A, Jones DW et al. A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biol Psychiatry 2000; 47: 643-649
14. Heinz A, Ragan P et al. Reduced central serotonin transporters in alcoholism. Am J Psychiatry 1998; 155: 1544-1549
15. Jönssen EG, Melke BJ, Abou Jamra R, Schumacher J, Westberg L, Ivo R, Cichon S, Propping P, Nothen MM, Eriksson E, Sedvall GC. Monoamine related functional gene variants and relationships to monoamine metabolite concentrations in CSF of healthy volunteers. BMC Psychiatry 2004; 4: 4
16. Jönsson EG, Nothen MM, Gustavsson JP et al. Polymorphisms in the dopamine, serotonin, and norepinephrine transporter genes and their relationships to monoamine metabolite concentrations in CSF of healthy volunteers. Psychiatry Res 1998; 79: 1-9
17. Keedwell PA, Poon L et al. Salivary cortisol measurements during a medically assisted alcohol withdrawal. Addict Biol 2001; 6: 247-256
18. Lappalainen J, Long JC, Virkkunen M, Ozaki N, Goldman D, Linnoila M. HTR2C Cys23Ser polymorphism in relation to CSF monoamine metabolite concentrations and DSM-III-R psychiatric diagnoses. Biol Psychiatry 1999; 46: 821-826
19. LeMarquand D, Phil RO et al. Serotonin and alcohol intake, abuse and dependence: findings of animal studies. Biol Psychiatry 1994; 36: 395-421
20. Lovallo WR, Dickensheets SL et al. Blunted stress cortisol response in abstinent alcoholic and polysubstance-abusing men. Alcoholism: Clin Exp Res 2000; 24: 651-658
21. Mihic SH, Ye Q et al. Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors. Nature 1997; 389: 385-389
22. Miksys S, Rao Y, Hoffmann E, Mash DC, Tyndale RF. Regional and cellular expression of CYP2D6 in human brain: higher levels in alcoholics. J Neurochem 2002; 82: 1376-1387
23. Milatovich A, Hsieh CL, Bonaminio G, Tecott L, Julius D, Francke U. Serotonin receptor 1c gene assigned to X chromosome in human (band q24) and mouse (bands D-F4). Hum Mol Genet 1992; 1: 681-684
24. Moss HB, Yao JK et al. Serotonergic responsivity and behavioral dimensions in antisocial personality disorder with substance abuse. Biol Psychiatry 1990; 28: 325-338
25. Naranjo CA, Brenner KE et al. Effects of citalopram and a brief psychosocial intervention on alcohol intake, dependence and problems. Addiction 1995; 90: 87-99
26. Okada M, Northrup J, Ozaki N, Russell JT, Linnoila M, Goldman D. Modification of human 5-HT(2C) receptor function by Cys23Ser, an abundant, naturally occurring amino-acid substitution. Mol Psychiatry 2004; 9: 55-64
27. Schuckit MA, Smith TL. An 8-year follow-up of 450 sons of alcoholic and control subjects. Arch Gen Psychiatry 1996; 53: 202-210
28. Schurmeyer TH, Brademann G et al. Effect of fenfluramine on episodic ACTH and cortisol secretion. Clin Endocrinol 1996; 45: 39-45
29. Tiihonen J, Ryyanen OP et al. Citalopram in the treatment of alcoholism: a double-blind, placebo-controlled study. Pharmacopsychiatry 1996; 29: 27-29
30. Vescovi PP, DiGennaro C et al. Hormonal (ACTH, cortisol, beta-endorphin, and met-enkephalin) and cardiovascular responses to hyperthermic stress in chronic alcoholics. Alcohol Clin Exp Res 1997; 21: 1195-1198
31. Virkkunen M, Linnoila M. Brain serotonin, type II alcoholism and impulsive violence. Journal of Studies on Alcohol 1993; (Suppl 11): 163-169
32. Marchesi C, Cantoni A, Fonto S, Giannelli MR, Maggini C. Predictors of symptom resolution in panic disorder after one year of pharmacological treatment: a naturalistic study. Pharmacopsychiatry 2006; 39: 60-65